These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

HB Wealth Management LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.9% during the fourth quarter, according to the company in its most recent Form 13F filing with ...

A review of BB Biotech’s portfolio and results for 2024 as well as the outlook for 2025 will be included in the Annual Report, to be published on February 21, 2025. The figures and information ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough to gauge which innovative biotech firms will have something genuinely ground ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

Detailed price information for Virtus Lifesci Biotech Clinical Trials ETF (BBC-A) from The Globe and Mail including charting and trades.

ADMA had a big year in 2024; as it moved toward increased commercialization of some of its products, revenue and net income ...

iShares U.S. Healthcare ETF (IYH) iShares U.S. Healthcare ETF offers exposure to 105 U.S. healthcare equipment and services, pharmaceuticals, and biotechnology companies by tracking the Russell 1000 ...

The sharp selloff also triggered a mass exodus from the benchmark small-cap ETF, with investors pulling more than $871 million out of IWM in the week ending Tuesday. It was also one of the three funds ...

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.

Capital Investment Advisors LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% ...

Explore why the iShares Russell 2000 ETF IWM has crashed hard this year amid the ongoing bond yield surge in the US.